SMTL ID : 2ds1.1

Human cyclin dependent kinase 2 complexed with the CDK4 inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x 1CD: (13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25 ),18,20-HEPTAENE-23,26-DIONE(Non-covalent)

1CD.1: 16 residues within 4Å: Chain A: I.10, E.12, G.13, V.18, A.31, K.33, V.64, F.80, E.81, H.82, V.83, H.84, D.86, Q.131, L.134, D.145 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:A.31, A:V.64, A:F.80, A:F.80, A:L.134, A:L.134 Hydrogen bonds: A:V.83, A:V.83, A:D.145

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kawanishi, N. et al., Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure. Bioorg.Med.Chem.Lett. (2006)

Release Date

2007-06-19

Peptides

Cell division protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cell division protein kinase 2

Related Entries With Identical Sequence